Glenn F. Tilton's most recent trade in Phillips 66 was a trade of 1,423 Common Stock done at an average price of $140.6 . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phillips 66 | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 140.56 per share. | 15 Jan 2026 | 1,423 | 74,437 (0%) | 0% | 140.6 | 200,017 | Common Stock |
| AbbVie | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,203 | 51,564 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Phillips 66 | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 118.78 per share. | 15 Jan 2025 | 1,684 | 71,618 (0%) | 0% | 118.8 | 200,020 | Common Stock |
| AbbVie | Glenn F. Tilton | Director | 03 May 2024 | 1,322 | 50,361 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| Phillips 66 | F. Tilton Glenn | Director | Grant, award, or other acquisition of securities at price $ 131.31 per share. | 16 Jan 2024 | 1,524 | 68,775 (0%) | 0% | 131.3 | 200,116 | Common Stock |
| Phillips 66 | Glenn F. Tilton | Director | Other type of transaction at price $ 93.79 per share. | 20 Jun 2023 | 39 | 66,209 (0%) | 0% | 93.8 | 3,658 | Common Stock |
| AbbVie | Glenn F. Tilton | Director | 05 May 2023 | 1,450 | 49,039 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Glenn F. Tilton | Director | 28 Apr 2023 | 2,230 | 34,700 | - | - | Stock Equivalent Units | ||
| Phillips 66 | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 103.68 per share. | 17 Jan 2023 | 1,929 | 65,876 (0%) | 0% | 103.7 | 200,008 | Common Stock |
| AbbVie | Glenn F. Tilton | Director | 06 May 2022 | 1,421 | 47,589 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| Abbott | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,602 | 46,128 (0%) | 0% | 0 | Common shares without par value | |
| Phillips 66 | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 22,500 | 62,538 (0%) | 0% | - | Common Stock | |
| Phillips 66 | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 87.57 per share. | 14 Jan 2022 | 2,284 | 40,038 (0%) | 0% | 87.6 | 200,010 | Common Stock |
| AbbVie | Glenn F. Tilton | Director | 07 May 2021 | 1,681 | 46,168 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| Abbott | Glenn F. Tilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 1,499 | 44,526 (0%) | 0% | 0 | Common shares without par value |